Growth Metrics

Baxter International (BAX) Receivables - Other (2016 - 2025)

Baxter International (BAX) has disclosed Receivables - Other for 17 consecutive years, with $147.0 million as the latest value for Q4 2025.

  • Quarterly Receivables - Other rose 10.53% to $147.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $147.0 million through Dec 2025, up 10.53% year-over-year, with the annual reading at $147.0 million for FY2025, 10.53% up from the prior year.
  • Receivables - Other for Q4 2025 was $147.0 million at Baxter International, up from $138.0 million in the prior quarter.
  • The five-year high for Receivables - Other was $229.0 million in Q3 2022, with the low at $7.0 million in Q2 2021.
  • Average Receivables - Other over 5 years is $153.8 million, with a median of $154.5 million recorded in 2024.
  • The sharpest move saw Receivables - Other crashed 94.93% in 2021, then skyrocketed 3085.71% in 2022.
  • Over 5 years, Receivables - Other stood at $81.0 million in 2021, then surged by 114.81% to $174.0 million in 2022, then decreased by 5.17% to $165.0 million in 2023, then fell by 19.39% to $133.0 million in 2024, then rose by 10.53% to $147.0 million in 2025.
  • According to Business Quant data, Receivables - Other over the past three periods came in at $147.0 million, $138.0 million, and $129.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.